JPRN-UMIN000014333已完成未知
Comparison of DPP4 inhibitors versus luseogliflozin, a SGLT2 inhibitor using cotinuous glucose monitoring (CGM) - Comparison of DPP4 inhibitors versus luseogliflozin, a SGLT2 inhibitor using cotinuous glucose monitoring (CGM)
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •liver or renal dysfunction
研究者
相似试验
已完成
4 期
Comparison of DPP-4 Inhibitors versus Dapagliflozin in combination with insulin using continuous glucose monitoring in patients with type 2 diabetes mellitus -prospective randomized controlled trialtype 2 diabetes mellitusJPRN-UMIN000015033Hokkaido University Hospital36
已完成
不适用
Comparison of DPP-4 inhibitors, vildagliptin and linagliptin in type2 diabetesType 2 diabetes mellitusJPRN-UMIN000010445Yokohama City University Medical Center100
已完成
不适用
Comparison of efficacy between DPP-4 inhibitor up-titration vs addition of acarbose in T2DMtype 2 diabetes mellitusJPRN-UMIN000005471Saitama Medical University40
已完成
不适用
Effects of DPP4 inhibitor, sitagliptin or Sulfonylurea on intrahepatic adipose mass and lipid metabolism in patients with type 2 diabetes accompanied by fatty liver : a prospective randomized, open-label trialType 2 diabetesJPRN-UMIN000013356St.Marianna University School of Medicine60
招募中
不适用
Comparison of effects of a DPP-4 inhibitor and an alpha-glucosidase inhibitor on visceral fat and oxidative stress in type 2 diabetes mellitustype 2 diabetes mellitusJPRN-UMIN000011864Tokyo Women's Medical University100